Cln3Δex7/8 knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth

被引:150
作者
Cotman, SL
Vrbanac, V
Lebel, LA
Lee, RL
Johnson, KA
Donahue, LR
Teed, AM
Antonellis, K
Bronson, RT
Lerner, TJ
MacDonald, ME
机构
[1] Massachusetts Gen Hosp, Mol Neurogenet Unit, Charlestown, MA 02129 USA
[2] Jackson Lab, Bar Harbor, ME 04609 USA
关键词
D O I
10.1093/hmg/11.22.2709
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Juvenile-onset neuronal ceroid lipofuscinosis (JNCL; Batten. disease) features hallmark membrane deposits and loss of central nervous system (CNS) neurons: Most cases of the disease are due to recessive inheritance of an similar to1 kb deletion in the CLN3 gene, encoding battenin. To investigate the common JNCL mutation, we have introduced an identical genomic DNA deletion into the murine CLN3 homologue (Cln3) to create Cln3(Deltaex7/8) knock-in mice. The Cln3(Deltaex7/8) allele produced alternatively spliced mRNAs, including a variant predicting non-truncated protein, as well as mutant battenin that was detected in the cytoplasm of cells in the periphery and CNS. Moreover, Cln3(Deltaex7/8) homozygotes exhibited accrual of JNCL-like membrane deposits from before birth, in proportion to battenin levels, which were high in liver and select neuronal populations. However, liver enzymes and CNS development were normal. Instead, Cln3(Deltaex7/8) mice displayed recessively inherited degenerative changes in retina, cerebral cortex and cerebellum, as well as neurological deficits and premature death. Thus, the harmful impact of the common JNCL mutation on the CNS was not well correlated with membrane deposition per se, suggesting instead a specific battenin activity that is essential for the survival of CNS neurons.
引用
收藏
页码:2709 / 2721
页数:13
相关论文
共 32 条
[1]  
Bronson RT, 1998, AM J MED GENET, V77, P289, DOI 10.1002/(SICI)1096-8628(19980526)77:4<289::AID-AJMG8>3.0.CO
[2]  
2-I
[3]   Neural acid extraneural expression of the neuronal ceroid lipofuscinoses genes CLN1, CLN2, and CLN3:: Functional implications for CLN3 [J].
Chattopadhyay, S ;
Pearce, DA .
MOLECULAR GENETICS AND METABOLISM, 2000, 71 (1-2) :207-211
[4]   THE HUMAN BLUE OPSIN PROMOTER DIRECTS TRANSGENE EXPRESSION IN SHORT-WAVE CONES AND BIPOLAR CELLS IN THE MOUSE RETINA [J].
CHEN, J ;
TUCKER, CL ;
WOODFORD, B ;
SZEL, A ;
LEM, J ;
GIANELLABORRADORI, A ;
SIMON, MI ;
BOGENMANN, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) :2611-2615
[5]   Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse [J].
Gao, HL ;
Boustany, RMN ;
Espinola, JA ;
Cotman, SL ;
Srinidhi, L ;
Antonellis, KA ;
Gillis, T ;
Qin, XB ;
Liu, SM ;
Donahue, LR ;
Bronson, RT ;
Faust, JR ;
Stout, D ;
Haines, JL ;
Lerner, TJ ;
MacDonald, ME .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (02) :324-335
[6]   Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice [J].
Gupta, P ;
Soyombo, AA ;
Atashband, A ;
Wisniewski, KE ;
Shelton, JM ;
Richardson, JA ;
Hammer, RE ;
Hofmann, SL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13566-13571
[7]   SHEEP AND OTHER ANIMALS WITH CEROID-LIPOFUSCINOSES - THEIR RELEVANCE TO BATTEN DISEASE [J].
JOLLY, RD ;
MARTINUS, RD ;
PALMER, DN .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1992, 42 (04) :609-614
[8]  
Katz ML, 1999, J NEUROSCI RES, V57, P551
[9]   HUMAN FORMS OF NEURONAL CEROID-LIPOFUSCINOSIS (BATTEN-DISEASE) - CONSENSUS ON DIAGNOSTIC-CRITERIA, HAMBURG 1992 [J].
KOHLSCHUTTER, A ;
GARDINER, RM ;
GOEBEL, HH .
JOURNAL OF INHERITED METABOLIC DISEASE, 1993, 16 (02) :241-244
[10]   SPECIFIC STORAGE OF SUBUNIT C OF MITOCHONDRIAL ATP SYNTHASE IN LYSOSOMES OF NEURONAL CEROID LIPOFUSCINOSIS (BATTENS DISEASE) [J].
KOMINAMI, E ;
EZAKI, J ;
MUNO, D ;
ISHIDO, K ;
UENO, T ;
WOLFE, LS .
JOURNAL OF BIOCHEMISTRY, 1992, 111 (02) :278-282